C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2002
11/05/2002	US6475728 Method for identifying and/or analyzing biological substances, present in a conductive liquid, device and affinity sensor used for implementing said method
11/05/2002	US6475727 Primers and methods for the detection of disseminated tumor cells
11/05/2002	US6475726 Method for identifying validated target and assay combinations for drug development
11/05/2002	US6475724 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
11/05/2002	US6475722 Surface treatments for DNA processing devices
11/05/2002	US6475721 Detection of mutation and polymorphisms; solid carrier for quantitative analysis
11/05/2002	US6475720 Chromosome-specific staining to detect genetic rearrangements associated with chromosome 3 and/or chromosome 17
11/05/2002	US6475719 Determination of factors affecting gene regulation and/or gene replication
11/05/2002	US6475718 Genetically engineered eukaryotic cell; for prevention of viral infections; viricides
11/05/2002	US6475534 Ginkgo biloba composition, method to prepare the same and uses thereof
11/05/2002	US6475487 Treatment of a patient by administering an antibody that inhibits cathepsin O
11/05/2002	US6475363 Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis
11/05/2002	EP0948645A4 Cleaved amplified rflp detection methods
11/05/2002	CA2251867C Transistor-based molecular detection apparatus and method
11/05/2002	CA2235128C Transistor-based apparatus and method for molecular detection and field enhancement
11/05/2002	CA2174753C Nucleotidic fragments capable of hybridizing specifically to rdna or rrna of a rickettsia and utilisation as probes or initiators
11/05/2002	CA2136831C Uses of nucleic acid analogues in the inhibition of nucleic acid amplification
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
11/04/2002	EP1131631A4 In situ method of analyzing cells
10/2002
10/31/2002	WO2002086511A2 Method for testing samples containing prion protein for the possible presence of the prpsc form
10/31/2002	WO2002086483A1 Biosensor
10/31/2002	WO2002086454A1 Multi-format sample processing devices, methods and systems
10/31/2002	WO2002086450A2 Compositions and methods for the identification of protein interactions in vertebrate cells
10/31/2002	WO2002086448A2 Detection of microsatellite instability and its use in diagnosis of tumors
10/31/2002	WO2002086447A2 Method for assessing risk for cardiac dysrhythmia in a human subject
10/31/2002	WO2002086446A2 Compositions and methods for gender sorting
10/31/2002	WO2002086444A2 Methods and compositions for mutation analysis
10/31/2002	WO2002086443A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
10/31/2002	WO2002086441A2 Amplification and detection of mycoplasma pneumoniae
10/31/2002	WO2002086169A1 Methods for rapid screening of polymorphisms, mutations and methylation
10/31/2002	WO2002086168A1 Biomolecule characterization using mass spectrometry and affinity tags
10/31/2002	WO2002086167A1 Methods for nucleic acid manipulation
10/31/2002	WO2002086166A1 Method for analyzing nucleic acid reactions
10/31/2002	WO2002086165A1 Biological sample processing methods and compositions that include surfactants
10/31/2002	WO2002086164A1 Methods for identifying the evolutionarily conserved sequences
10/31/2002	WO2002086163A1 Methods for high throughput genome analysis using restriction site tagged microarrays
10/31/2002	WO2002086162A1 Molecular detection chip including mosfet, molecular detection device employing the chip, and molecular detection method using the device
10/31/2002	WO2002086161A1 Method of estimating diplotype from genotype of individual
10/31/2002	WO2002086160A1 Hybridization probes
10/31/2002	WO2002086159A2 Method for genotyping microsatellite dna markers
10/31/2002	WO2002086158A2 Method to analyse the kit genotype of pigs
10/31/2002	WO2002086157A2 Use of semaphorin 3a for diagnosing and treating cancer, especially prostate cancer
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086155A2 Method for the preferential nucleic acid amplification of selected nucleic acid regions
10/31/2002	WO2002086154A2 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages
10/31/2002	WO2002086153A1 DETERMINING RESISTANCE TO A $G(b)-LACTAM-CONTAINING ANTIBIOTIC BY COMPARING THE RATIO OF TWO $G(b)-LACTAMASE GENES
10/31/2002	WO2002086152A1 Non-recombinant cell lines capable of expressing predominantly cyclic nucleotide phophodiesterase 4 (pde4) subtype b and their use for the screening of pde4 subtype-specific modulators
10/31/2002	WO2002086151A1 Method of assaying biological component
10/31/2002	WO2002086150A2 Method for detecting a reaction by measuring a pm change
10/31/2002	WO2002086149A2 Diagnosis by sensing volatile components
10/31/2002	WO2002086148A1 Particle based assay system
10/31/2002	WO2002086147A2 Single nucleotide polymorphisms diagnostic for schizophrenia
10/31/2002	WO2002086145A2 Biological sample processing methods and compositions that include surfactants
10/31/2002	WO2002086123A2 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/31/2002	WO2002086121A1 Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides
10/31/2002	WO2002086113A2 Enzyme and snp marker for disease
10/31/2002	WO2002086107A2 A method for differentiating stem cells into insulin-producing cells
10/31/2002	WO2002086097A2 Methods for identifying the target of a compound which inhibits cellular proliferation
10/31/2002	WO2002086095A2 Transcription factor network discovery methods
10/31/2002	WO2002086090A2 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002	WO2002086088A2 Polymerases with charge-switch activity and methods of generating such polymerases
10/31/2002	WO2002086087A2 Cytokine protein family
10/31/2002	WO2002086086A2 Methods to identify agents that bind the flap-tip helix of rna polymerase
10/31/2002	WO2002086084A2 Sequence characteristics of bladder cancer
10/31/2002	WO2002086081A2 Methods and systems for identifying proteins
10/31/2002	WO2002086075A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs
10/31/2002	WO2002086071A2 Cancer-testis antigens
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002086065A2 Induction of apoptosis by cellular stress
10/31/2002	WO2002086055A1 Method for minimizing optical interference during antibiotic susceptibility readings in a microbiological analyzer
10/31/2002	WO2002086054A1 Method for maintaining test integrity within a microbiological test array
10/31/2002	WO2002086051A2 Nucleic acid analysis by mass differentiable oligomers
10/31/2002	WO2002086050A2 Ion channel polynucleotide arrays comprising non-conserved regions identifying ion channel family member expression profiles
10/31/2002	WO2002085943A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085937A2 Inflammation-specific peptides and the uses thereof
10/31/2002	WO2002085936A1 Mutants of green fluorescent protein
10/31/2002	WO2002085923A2 In vivo incorporation of unnatural amino acids
10/31/2002	WO2002085791A2 Pcr-based monitoring in wastewater biotreatment systems
10/31/2002	WO2002085298A2 Method for detecting breast cancer cells
10/31/2002	WO2002085295A2 Methods and compositions for the modulation of biofilm formation
10/31/2002	WO2002085289A2 Modulators of angiogenesis
10/31/2002	WO2002085285A2 Methods and reagents for regulating bone and cartilage formation
10/31/2002	WO2002085093A2 Replikin peptides and uses thereof
10/31/2002	WO2002070737A8 Compositions and methods relating to osteoarthritis
10/31/2002	WO2002066960A9 Drug discovery system with auto-sampler for multicellular organisms in a sorting flow cytometer
10/31/2002	WO2002066681A9 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
10/31/2002	WO2002064743A3 Confirming the exon content of rna transcripts by pcr using primers complementary to each respective exon
10/31/2002	WO2002064161A9 Method and compositions for immunization with the pseudomonas v antigen
10/31/2002	WO2002062963A3 Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
10/31/2002	WO2002062207A3 Myeloperoxidase, a risk indicator for cardiovascular disease
10/31/2002	WO2002062197A3 Markers for disease susceptibility and targets for therapy
10/31/2002	WO2002061105A9 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
10/31/2002	WO2002061048A3 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses
10/31/2002	WO2002059375A9 Determination of ugt2b7 gene polymorphisms for predicting ugt2b7 substrate toxicity and for optimising drug dosage
10/31/2002	WO2002059148A9 A method for identification, isolation and production of antigens to a specific pathogen
10/31/2002	WO2002055680A3 Morphometric tissue or cell preparation
10/31/2002	WO2002044416A3 Sulfonated diarylrhodamine dyes as fluorescent labels
10/31/2002	WO2002042489A9 Methods involving a t cell protein tyrosine phosphatase
10/31/2002	WO2002042455A3 Modifier of organelle metalbolism

1 ... 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 ... 3003